These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 7768077
1. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W. Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077 [Abstract] [Full Text] [Related]
2. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W. Chirality; 1993 May; 5(1):15-9. PubMed ID: 8383518 [Abstract] [Full Text] [Related]
3. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study. Egginger G, Lindner W, Kahr S, Stoschitzky K. Chirality; 1993 May; 5(7):505-12. PubMed ID: 8240927 [Abstract] [Full Text] [Related]
4. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Leenen FH, Davies RA, Fourney A. Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044 [Abstract] [Full Text] [Related]
5. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers. Paradiso-Hardy FL, Walker SE, Bowles SK. Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351 [Abstract] [Full Text] [Related]
6. beta-blockade, atrial natriuretic peptide and exercise. Kantola I, Tarssanen L, Scheinin M, Ruskoaho H, Viinamäki O, Kaila T. Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991 [Abstract] [Full Text] [Related]
7. Exercise increases plasma concentrations of (R)- and (S)-propranolol. Stoschitzky K, Schumacher M, Stark G, Dimai HP, Stauber R, Stoschitzky P, Krejs GJ, Klein W, Lindner W. Eur J Clin Pharmacol; 1996 Jan; 50(4):339-42. PubMed ID: 8803530 [Abstract] [Full Text] [Related]
8. Stereoselective effects of (R)- and (S)-carvedilol in humans. Stoschitzky K, Koshucharova G, Lercher P, Maier R, Sakotnik A, Klein W, Liebmann PM, Lindner W. Chirality; 2001 Jul; 13(7):342-6. PubMed ID: 11400186 [Abstract] [Full Text] [Related]
9. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin). Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S. Chirality; 1994 Jul; 6(3):169-74. PubMed ID: 8024947 [Abstract] [Full Text] [Related]
10. Hemodynamic effects of reboxetine in healthy male volunteers. Denolle T, Pellizzoni C, Jannuzzo MG, Poggesi I. Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064 [Abstract] [Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. Wójcicki J, Jaroszynska M, Droździk M, Pawlik A, Gawrońska-Szklarz B, Sterna R. Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321 [Abstract] [Full Text] [Related]
12. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose. Marier JF, Pichette V, du Souich P. Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303 [Abstract] [Full Text] [Related]
13. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ. Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615 [Abstract] [Full Text] [Related]
15. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Joannides R, Moore N, Iacob M, Compagnon P, Lerebours G, Menard JF, Thuillez C. Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867 [Abstract] [Full Text] [Related]
16. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol]. Stoschitzky K, Lindner W. Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978 [Abstract] [Full Text] [Related]
17. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M. Chirality; 1997 Apr 15; 9(3):297-302. PubMed ID: 9176996 [Abstract] [Full Text] [Related]
18. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study. Sardina M, Warrington SJ, Boyce M, Johnston A, Bianchini C. J Cardiovasc Pharmacol; 1995 Apr 15; 26 Suppl 4():S80-90. PubMed ID: 8839231 [Abstract] [Full Text] [Related]
19. Influence of beta-blockers on melatonin release. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W. Eur J Clin Pharmacol; 1999 Apr 15; 55(2):111-5. PubMed ID: 10335905 [Abstract] [Full Text] [Related]
20. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels. Collett JT, Hendrickson JA, Chew CY, Shah PM, Laddu AR, Singh BN. Int J Clin Pharmacol Ther Toxicol; 1981 Nov 15; 19(11):473-8. PubMed ID: 6117519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]